612TiP - TRIUMPH Study: A multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer (EPOC1602)

Autor: Nakamura, Y., Okamoto, W., Sawada, K., Komatsu, Y., Kato, K., Taniguchi, H., Kato, T., Nishina, T., Esaki, T., Nomura, H., Fukutani, M., Fukui, M., Hasegawa, H., Yonemura, M., Fuse, N., Sato, A., Fujii, S., Ohtsu, A., Yoshino, T.
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v207-v207
Databáze: ScienceDirect